ATE307132T1 - Purin derivate als a2b adenosin rezeptor antagonisten - Google Patents
Purin derivate als a2b adenosin rezeptor antagonistenInfo
- Publication number
- ATE307132T1 ATE307132T1 AT02749704T AT02749704T ATE307132T1 AT E307132 T1 ATE307132 T1 AT E307132T1 AT 02749704 T AT02749704 T AT 02749704T AT 02749704 T AT02749704 T AT 02749704T AT E307132 T1 ATE307132 T1 AT E307132T1
- Authority
- AT
- Austria
- Prior art keywords
- optionally substituted
- receptor antagonists
- adenosine receptor
- purine derivatives
- sup
- Prior art date
Links
- 229940121359 adenosine receptor antagonist Drugs 0.000 title abstract 2
- 239000000296 purinergic P1 receptor antagonist Substances 0.000 title abstract 2
- 101150078577 Adora2b gene Proteins 0.000 title 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title 1
- 150000003212 purines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010012689 Diabetic retinopathy Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000005017 substituted alkenyl group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000004426 substituted alkynyl group Chemical group 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30220801P | 2001-06-29 | 2001-06-29 | |
| PCT/US2002/020631 WO2003002566A1 (en) | 2001-06-29 | 2002-06-27 | Purine derivatives as a2b adenosine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE307132T1 true ATE307132T1 (de) | 2005-11-15 |
Family
ID=23166757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02749704T ATE307132T1 (de) | 2001-06-29 | 2002-06-27 | Purin derivate als a2b adenosin rezeptor antagonisten |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6770651B2 (de) |
| EP (1) | EP1401837B1 (de) |
| JP (1) | JP4335000B2 (de) |
| KR (2) | KR100883292B1 (de) |
| AT (1) | ATE307132T1 (de) |
| CA (1) | CA2451244C (de) |
| DE (1) | DE60206756T2 (de) |
| DK (1) | DK1401837T3 (de) |
| ES (1) | ES2247356T3 (de) |
| WO (1) | WO2003002566A1 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20010465A1 (it) * | 2001-07-31 | 2003-01-31 | Sigma Tau Ind Farmaceuti | Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam |
| AU2002357295A1 (en) * | 2001-12-18 | 2003-06-30 | Cv Therapeutics, Inc. | A2a adenosine receptor antagonists |
| WO2004106337A1 (en) * | 2003-05-06 | 2004-12-09 | Cv Therapeutics, Inc. | Xanthine derivatives as a2b adenosine receptor antagonists |
| NL1023355C2 (nl) * | 2003-05-07 | 2004-11-09 | Oce Tech Bv | Hot melt inkt omvattend een mengsel van kleurstoffen. |
| TWI372050B (en) | 2003-07-03 | 2012-09-11 | Astex Therapeutics Ltd | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles |
| CA2533402A1 (en) * | 2003-07-22 | 2005-02-03 | Cv Therapeutics, Inc. | A1 adenosine receptor antagonists |
| WO2005047268A2 (en) * | 2003-11-10 | 2005-05-26 | X-Ceptor Therapeutics, Inc. | Substituted pyrimidine compositions and methods of use |
| US20080280926A1 (en) * | 2003-12-16 | 2008-11-13 | Palle Venkata P | Phosphodiesterase Inhibitors |
| MX2007008008A (es) | 2004-12-30 | 2007-11-12 | Astex Therapeutics Ltd | Compuestos de pirazol que modulan la actividad de las cinasas cdk, gsk y aurora. |
| ES2270715B1 (es) | 2005-07-29 | 2008-04-01 | Laboratorios Almirall S.A. | Nuevos derivados de pirazina. |
| CA2620182A1 (en) | 2005-08-22 | 2007-03-01 | Dennis A. Carson | Tlr agonists |
| WO2007030438A2 (en) * | 2005-09-06 | 2007-03-15 | Pharmacopeia, Inc. | Aminopurine derivatives for treating neurodegenerative diseases |
| ES2274712B1 (es) | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
| JP5474354B2 (ja) | 2005-12-30 | 2014-04-16 | アステックス、セラピューティックス、リミテッド | 医薬化合物 |
| US8846697B2 (en) * | 2006-05-31 | 2014-09-30 | The Regents Of The University Of California | Purine analogs |
| US8435970B2 (en) | 2006-06-29 | 2013-05-07 | Astex Therapeutics Limited | Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea |
| US7470697B2 (en) * | 2006-09-01 | 2008-12-30 | Adenosine Therapeutics, Llc | Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2B adenosine receptors |
| EP2510946B1 (de) | 2007-02-07 | 2015-08-05 | The Regents of The University of California | Konjugate synthetischer TLR-Agonisten und Verwendung dafür |
| JP2011500716A (ja) * | 2007-10-16 | 2011-01-06 | ギリアード・パロ・アルト・インコーポレイテッド | A3アデノシン受容体アンタゴニスト |
| WO2009099650A2 (en) * | 2008-02-07 | 2009-08-13 | Carson Dennis A | Treatment of bladder diseases with a tlr7 activator |
| JP5460690B2 (ja) | 2008-03-26 | 2014-04-02 | アドヴィナス・セラピューティックス・リミテッド | アデノシンレセプターアンタゴニストとしてのヘテロ環化合物 |
| EP2306838A4 (de) * | 2008-07-16 | 2011-12-14 | King Pharmaceuticals Res & Dev | Verfahren zur behandlung von atherosklerose |
| KR20110117705A (ko) | 2009-02-11 | 2011-10-27 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 톨-유사 수용체 조정제 및 질병의 치료 |
| BRPI1009398A2 (pt) | 2009-03-13 | 2016-03-08 | Advinus Therapeutics Private Ltd | compostos de pirimidina fundida substituída |
| SI2408775T1 (sl) * | 2009-03-20 | 2015-08-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Oksidirani derivati triazolilpurinov, ki so uprabni kot ligandi receptorja adenozina A2A, in njihova uporaba kot zdravila |
| EP2499142B1 (de) | 2009-11-09 | 2016-09-21 | Advinus Therapeutics Limited | Substituierte kondensierte pyrimidinverbindungen, ihre herstellung und ihre verwendung |
| KR20130088834A (ko) | 2010-06-30 | 2013-08-08 | 길리애드 사이언시즈, 인코포레이티드 | 폐 고혈압의 치료를 위한 a2b 아데노신 수용체 길항제의 용도 |
| EP2616470B1 (de) | 2010-09-13 | 2016-10-12 | Advinus Therapeutics Limited | Purinverbindungen als prodrugs von a2b-adenosinrezeptorantagonisten, ihr verfahren und medizinische anwendung |
| DE102011005232A1 (de) | 2011-03-08 | 2012-09-13 | AristoCon GmbH & Co. KG | Adenosin und seine Derivate zur Verwendung in der Schmerztherapie |
| AR085942A1 (es) | 2011-04-07 | 2013-11-06 | Gilead Sciences Inc | Uso de receptor de aadenosina para tratar la insuficiencia cardiaca y la arritmia en pacientes posinfarto de miocardio |
| CA2969587A1 (en) * | 2014-12-05 | 2016-06-09 | Centre National De La Recherche Scientifique (Cnrs) | Compounds for treating cystic fibrosis |
| TWI746545B (zh) * | 2016-04-26 | 2021-11-21 | 日商大日本住友製藥股份有限公司 | 經取代嘌呤衍生物 |
| US11697851B2 (en) | 2016-05-24 | 2023-07-11 | The Regents Of The University Of California | Early ovarian cancer detection diagnostic test based on mRNA isoforms |
| WO2020181050A1 (en) | 2019-03-05 | 2020-09-10 | Sperovie Biosciences, Inc. | Compounds, compositions, and methods for the treatment of disease |
| WO2024105159A1 (en) * | 2022-11-16 | 2024-05-23 | University Of Zurich | Ligands of the m6a-rna readers |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954504A (en) * | 1986-11-14 | 1990-09-04 | Ciba-Geigy Corporation | N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity |
| US6545002B1 (en) | 1999-06-01 | 2003-04-08 | University Of Virginia Patent Foundation | Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors |
| BR0013673A (pt) * | 1999-08-31 | 2002-05-28 | Univ Vanderbilt | Antagonistas seletivos de receptores de adenosina a2b |
| ITRM20010465A1 (it) * | 2001-07-31 | 2003-01-31 | Sigma Tau Ind Farmaceuti | Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam |
| US6897208B2 (en) * | 2001-10-26 | 2005-05-24 | Aventis Pharmaceuticals Inc. | Benzimidazoles |
| AU2002357295A1 (en) * | 2001-12-18 | 2003-06-30 | Cv Therapeutics, Inc. | A2a adenosine receptor antagonists |
-
2002
- 2002-06-27 AT AT02749704T patent/ATE307132T1/de active
- 2002-06-27 DK DK02749704T patent/DK1401837T3/da active
- 2002-06-27 EP EP02749704A patent/EP1401837B1/de not_active Expired - Lifetime
- 2002-06-27 KR KR1020037017083A patent/KR100883292B1/ko not_active Expired - Lifetime
- 2002-06-27 ES ES02749704T patent/ES2247356T3/es not_active Expired - Lifetime
- 2002-06-27 US US10/184,494 patent/US6770651B2/en not_active Expired - Fee Related
- 2002-06-27 WO PCT/US2002/020631 patent/WO2003002566A1/en not_active Ceased
- 2002-06-27 DE DE60206756T patent/DE60206756T2/de not_active Expired - Lifetime
- 2002-06-27 JP JP2003508947A patent/JP4335000B2/ja not_active Expired - Lifetime
- 2002-06-27 CA CA2451244A patent/CA2451244C/en not_active Expired - Lifetime
- 2002-06-27 KR KR1020087020714A patent/KR100897219B1/ko not_active Expired - Lifetime
-
2004
- 2004-04-30 US US10/837,290 patent/US7238700B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20040209899A1 (en) | 2004-10-21 |
| JP4335000B2 (ja) | 2009-09-30 |
| KR100897219B1 (ko) | 2009-05-14 |
| ES2247356T3 (es) | 2006-03-01 |
| EP1401837B1 (de) | 2005-10-19 |
| JP2004536102A (ja) | 2004-12-02 |
| HK1064096A1 (en) | 2005-01-21 |
| EP1401837A1 (de) | 2004-03-31 |
| KR20080081208A (ko) | 2008-09-08 |
| DE60206756D1 (de) | 2006-03-02 |
| KR20040023634A (ko) | 2004-03-18 |
| US6770651B2 (en) | 2004-08-03 |
| DK1401837T3 (da) | 2005-11-07 |
| US7238700B2 (en) | 2007-07-03 |
| US20030064999A1 (en) | 2003-04-03 |
| CA2451244A1 (en) | 2003-01-09 |
| KR100883292B1 (ko) | 2009-02-11 |
| DE60206756T2 (de) | 2006-07-13 |
| WO2003002566A1 (en) | 2003-01-09 |
| CA2451244C (en) | 2012-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60206756D1 (de) | Purin derivate als a2b adenosin rezeptor antagonisten | |
| TR200201001T2 (tr) | Pürin türevleri | |
| ATE302205T1 (de) | Thieno- und furopyrimidin derivate als a2a- rezeptor antagonisten | |
| CY1117132T1 (el) | Παραγωγο θειαζολιου | |
| WO2003022216A3 (en) | Biaryl substituted purine derivatives as potent antiproliferative agents | |
| TR200200161T2 (tr) | Benzimidazol türevleri ve onların fosfodiesteraz olarak kullanımı. | |
| MXPA04003795A (es) | Compuestos de pirimidina y composiciones farmaceuticas que contienen los compuestos. | |
| DE60236719D1 (de) | Purinderivate als antagonisten an purinergen rezeptoren | |
| ATE424207T1 (de) | Triazoloä4,5-düpyrimidinderivate und ihre verwendung als antagonisten purinerger rezeptoren | |
| PT1140851E (pt) | 4-oxo-1,4-di-hidro-3-quinolinacarboxamidas como agentes antivirais | |
| PE20010430A1 (es) | DERIVADOS DE PURINA COMO AGONISTAS DEL RECEPTOR DE ADENOSINA A2a | |
| TNSN07154A1 (en) | Purine derivatives for use as adenosin a-2a receptor agonists | |
| ATE254132T1 (de) | Antivirale pyrimidin nucleoside derivate | |
| WO2003022805A3 (en) | Heterocycle substituted purines as antiproliferative agents | |
| LV12712A (lv) | Inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodekstrin and method | |
| BR0008770A (pt) | Derivado de pirimidina, processo para a preparação de um derivado de pirimidina, processo para a produção de um efeito anti-câncer em um animal de sangue quente, uso de um derivado de pirimidina, e, composição farmacêutica | |
| AR037680A1 (es) | Antagonistas del receptor de adenosina a2a de 5-amino-pirazolo-[4,3-e]-1,2,4-triazolo[1,5-c]-pirimidinas sustituidas, composiciones farmaceuticas que los comprenden, el uso de dichos compuestos, solos o en combinacion para la elaboracion de un medicamento utiles para el tratamiento de enfermedades d | |
| ATE266021T1 (de) | Imidazol-2-carbonsäureamid derivate als raf kinase inhibitoren | |
| ES2150903T3 (es) | Derivados de 2-aralcoxi y 2-alcoxi adenosina de utilidad como vasodilatadores coronarios y como agentes antihipertensivos. | |
| TR200401622T4 (tr) | Pürin türevleri | |
| WO2003022219A3 (en) | Biarylamino purine antiproliferative agents | |
| ATE407935T1 (de) | Thieno(3,2-d)pyrimidine und furano(3,2- d)pyrimidine und deren verwendung als antagonisten an purinergen rezeptoren | |
| ATE418555T1 (de) | A2a-adenosinrezeptorantagonisten | |
| CY1105879T1 (el) | Αζαδικυκλο παραγωγα ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
| WO2003068776A1 (en) | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1401837 Country of ref document: EP |